Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spigelman

Showing results (341-350 of 527) with videos related to

Pageof 53
Sort By:
Experimental Neurology|February 1, 1988
Effects of etoposide-induced blood-brain barrier disruption on brain water, intracranial pressure, and cerebral vasomotor toneP H Hollis, R A Zappulla, M K Spigelman, et al.
Neurosurgery|June 1, 1983
Intracarotid dehydrocholate infusion: a new method for prolonged reversible blood-brain barrier disruptionM K Spigelman, R A Zappulla, L I Malis, et al.
Neuron|August 1, 1993
Cell-permeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivoM Tymianski, M C Wallace, I Spigelman, et al.
Hereditary Cancer in Clinical Practice|February 18, 2016
When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in transMichelle Wong-Brown, Mary McPhillips, Margaret Gleeson, et al.
Neuropharmacology|July 8, 2018
Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activationYatendra Mulpuri, Vincent N Marty, Joseph J Munier, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 1, 1994
Mechanism of action and persistence of neuroprotection by cell-permeant Ca2+ chelatorsM Tymianski, I Spigelman, L Zhang, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 21, 2014
SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human isletsCatherine Hajmrle, Mourad Ferdaoussi, Gregory Plummer, et al.
Therapeutics and Clinical Risk Management|August 4, 2017
Thyroid cancer in a patient with Lynch syndrome - case report and literature reviewMonika Fazekas-Lavu, Andrew Parker, Allan D Spigelman, et al.
JCI Insight|October 5, 2016
Interleukin-1 signaling contributes to acute islet compensationCatherine Hajmrle, Nancy Smith, Aliya F Spigelman, et al.
Molecular Metabolism|April 21, 2025
Molecular correlates of glycine receptor activity in human β cellsAmanda Schukarucha Gomes, Cara E Ellis, Aliya F Spigelman, et al.
Pageof 53

Showing results (341-350 of 527) with videos related to

Sort By:
Pageof 53
Experimental Neurology|February 1, 1988
Effects of etoposide-induced blood-brain barrier disruption on brain water, intracranial pressure, and cerebral vasomotor toneP H Hollis, R A Zappulla, M K Spigelman, et al.
Neurosurgery|June 1, 1983
Intracarotid dehydrocholate infusion: a new method for prolonged reversible blood-brain barrier disruptionM K Spigelman, R A Zappulla, L I Malis, et al.
Neuron|August 1, 1993
Cell-permeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivoM Tymianski, M C Wallace, I Spigelman, et al.
Hereditary Cancer in Clinical Practice|February 18, 2016
When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in transMichelle Wong-Brown, Mary McPhillips, Margaret Gleeson, et al.
Neuropharmacology|July 8, 2018
Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activationYatendra Mulpuri, Vincent N Marty, Joseph J Munier, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 1, 1994
Mechanism of action and persistence of neuroprotection by cell-permeant Ca2+ chelatorsM Tymianski, I Spigelman, L Zhang, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 21, 2014
SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human isletsCatherine Hajmrle, Mourad Ferdaoussi, Gregory Plummer, et al.
Therapeutics and Clinical Risk Management|August 4, 2017
Thyroid cancer in a patient with Lynch syndrome - case report and literature reviewMonika Fazekas-Lavu, Andrew Parker, Allan D Spigelman, et al.
JCI Insight|October 5, 2016
Interleukin-1 signaling contributes to acute islet compensationCatherine Hajmrle, Nancy Smith, Aliya F Spigelman, et al.
Molecular Metabolism|April 21, 2025
Molecular correlates of glycine receptor activity in human β cellsAmanda Schukarucha Gomes, Cara E Ellis, Aliya F Spigelman, et al.
Pageof 53